Real-World watch: tracking a seizure Spray's safety
NCT ID NCT05313308
Summary
This study is observing how a midazolam oral spray works for people experiencing prolonged epileptic seizures in Japan. It aims to collect information on any side effects and how well the spray stops seizures in everyday medical practice. The study will follow about 50 participants for six months after they receive the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinigen selected site
RECRUITINGTokyo, Japan
Conditions
Explore the condition pages connected to this study.